| International Union of Pharmacology. LXXXIX. Update on the extended family of chemokine receptors and introducing a new nomenclature for atypical chemokine receptors F Bachelerie, A Ben-Baruch, AM Burkhardt, C Combadiere, JM Farber, ... Pharmacological reviews 66 (1), 1, 2014 | 1000* | 2014 |
| The inflammatory chemokines CCL2 and CCL5 in breast cancer G Soria, A Ben-Baruch Cancer letters 267 (2), 271-285, 2008 | 707 | 2008 |
| A possible role for CXCR4 and its ligand, the CXC chemokine stromal cell-derived factor-1, in the development of bone marrow metastases in neuroblastoma H Geminder, O Sagi-Assif, L Goldberg, T Meshel, G Rechavi, IP Witz, ... The Journal of Immunology 167 (8), 4747-4757, 2001 | 540 | 2001 |
| Signals and receptors involved in recruitment of inflammatory cells A Ben-Baruch, DF Michiel, JJ Oppenheim Journal of Biological Chemistry 270 (20), 11703-11706, 1995 | 537 | 1995 |
| The CC chemokine RANTES in breast carcinoma progression: regulation of expression and potential mechanisms of promalignant activity E Azenshtein, G Luboshits, S Shina, E Neumark, D Shahbazian, M Weil, ... Cancer research 62 (4), 1093-1102, 2002 | 483 | 2002 |
| Inflammation-associated immune suppression in cancer: the roles played by cytokines, chemokines and additional mediators A Ben-Baruch Seminars in cancer biology 16 (1), 38-52, 2006 | 454 | 2006 |
| Elevated expression of the CC chemokine regulated on activation, normal T cell expressed and secreted (RANTES) in advanced breast carcinoma G Luboshits, S Shina, O Kaplan, S Engelberg, D Nass, B Lifshitz-Mercer, ... Cancer research 59 (18), 4681-4687, 1999 | 398 | 1999 |
| Host microenvironment in breast cancer development: inflammatory cells, cytokines and chemokines in breast cancer progression: reciprocal tumor–microenvironment interactions A Ben-Baruch Breast cancer research 5, 1-6, 2002 | 368 | 2002 |
| Organ selectivity in metastasis: regulation by chemokines and their receptors A Ben-Baruch Clinical & experimental metastasis 25, 345-356, 2008 | 352 | 2008 |
| Inflammatory mediators in breast cancer: coordinated expression of TNFα & IL-1β with CCL2 & CCL5 and effects on epithelial-to-mesenchymal transition G Soria, M Ofri-Shahak, I Haas, N Yaal-Hahoshen, L Leider-Trejo, ... BMC cancer 11, 1-20, 2011 | 334 | 2011 |
| The multifaceted roles of chemokines in malignancy A Ben-Baruch Cancer and metastasis reviews 25, 357-371, 2006 | 326 | 2006 |
| NLRP3 inflammasome in fibroblasts links tissue damage with inflammation in breast cancer progression and metastasis N Ershaid, Y Sharon, H Doron, Y Raz, O Shani, N Cohen, L Monteran, ... Nature communications 10 (1), 4375, 2019 | 272 | 2019 |
| Chemokines at the crossroads of tumor-fibroblast interactions that promote malignancy P Mishra, D Banerjee, A Ben-Baruch Journal of leukocyte biology 89 (1), 31-39, 2011 | 267 | 2011 |
| Opiates transdeactivate chemokine receptors: δ and μ opiate receptor–mediated heterologous desensitization MC Grimm, A Ben-Baruch, DD Taub, OMZ Howard, JH Resau, JM Wang, ... The Journal of experimental medicine 188 (2), 317-325, 1998 | 250 | 1998 |
| CXCL10 promotes invasion-related properties in human colorectal carcinoma cells A Zipin-Roitman, T Meshel, O Sagi-Assif, B Shalmon, C Avivi, RM Pfeffer, ... Cancer research 67 (7), 3396-3405, 2007 | 241 | 2007 |
| Differential usage of the CXC chemokine receptors 1 and 2 by interleukin‐8, granulocyte chemotactic protein‐2 and epithelial‐cell‐derived neutrophil attractant‐78 A Wuyts, P Proost, JP Lenaerts, A Ben‐Baruch, J Van Damme, JM Wang European journal of biochemistry 255 (1), 67-73, 1998 | 207 | 1998 |
| Monocyte Chemotactic Protein-3 (MCP3) Interacts with Multiple Leukocyte Receptors: CC CKR1, A RECEPTOR FOR MACROPHAGE INFLAMMATORY PROTEIN-1α/RANTES, IS ALSO A FUNCTIONAL … A Ben-Baruch, L Xu, PR Young, K Bengali, JJ Oppenheim, JM Wang Journal of Biological Chemistry 270 (38), 22123-22128, 1995 | 197 | 1995 |
| Characterization of Synthetic Human Granulocyte Chemotactic Protein 2: Usage of Chemokine Receptors CXCR1 and CXCR2 and in Vivo Inflammatory Properties A Wuyts, N Van Osselaer, A Haelens, I Samson, P Herdewijn, ... Biochemistry 36 (9), 2716-2723, 1997 | 192 | 1997 |
| The chemokine CCL5 as a potential prognostic factor predicting disease progression in stage II breast cancer patients N Yaal-Hahoshen, S Shina, L Leider-Trejo, I Barnea, EL Shabtai, ... Clinical cancer research 12 (15), 4474-4480, 2006 | 191 | 2006 |
| Transendothelial migration of lymphocytes mediated by intraendothelial vesicle stores rather than by extracellular chemokine depots Z Shulman, SJ Cohen, B Roediger, V Kalchenko, R Jain, V Grabovsky, ... Nature immunology 13 (1), 67-76, 2012 | 190 | 2012 |
